ASTHMA - comparing the impact of vitamin D versus UVR on clinical and immune parameters.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing observational, clinical, and mechanistic studies without systematic review methodology
PubMed 28092390 · doi:10.1039/c6pp00407e
What was done
The authors conducted a narrative review evaluating epidemiological, clinical, and mechanistic literature on the roles of vitamin D status, oral vitamin D supplementation, and ultraviolet radiation (UVR/UVB) exposure in asthma management and immune regulation.
What was found
No numerical values or effect sizes are reported in the abstract. The authors report that observational studies link low circulating 25-hydroxyvitamin D with increased asthma incidence, severity, exacerbations, and poorer treatment response. Clinical trial meta-analyses suggest vitamin D supplementation reduces asthma exacerbations and steroid requirements despite substantial study heterogeneity. Studies evaluating UVR are largely confined to animal models or geographical latitude as a proxy, with no comprehensive human trials assessing UVB radiation on asthma outcomes.
Why it matters
This review distinguishes the evidence for oral vitamin D supplementation from ultraviolet light exposure, identifying a complete lack of interventional trial data evaluating direct UVB radiation for asthma.
Limits
This is a narrative review that provides no new human data, meta-analytic calculations, or quantitative metrics in the abstract. Interventional studies on vitamin D are noted to suffer from high heterogeneity in dosing regimens and designs, and direct UVB interventions in humans have not been tested.
Cited by
- context High levels of sun exposure decrease asthma symptoms or severity.